Descripción de la oferta
Job Title: Chief Business Officer (AI-Driven Drug Discovery SaaS – Antibody & Bioinformatics Focus)
Location: Netherlands (Relocation required OR minimum 1 week/month on-site presence)
Travel: Regular international travel required (Switzerland & United States essential due to client base)
AI Drug Discovery Saas Experience Is a MUST to be considered
About the Role
We are seeking a highly experienced Chief Business Officer (CBO) to lead global commercial strategy, partnerships, and revenue growth for a fast-scaling SaaS organisation operating at the forefront of AI-driven drug discovery, antibody engineering, and advanced bioinformatics.
The platform is deeply embedded within the R&D ecosystems of leading pharmaceutical organisations, including collaborations with multiple top 5 global pharma companies, supporting next-generation biologics discovery, sequencing analysis, and computational biology workflows.
This is a senior executive role requiring a proven leader who has successfully scaled AI-enabled life sciences or computational biology SaaS platforms within highly technical, enterprise-driven environments.
Key Responsibilities
Define and execute the global commercial strategy across pharma, biotech, and research markets
Own revenue generation, strategic partnerships, and long-term enterprise account growth
Lead and scale global business development, sales, and partnership teams
Build and maintain senior-level relationships across top-tier pharmaceutical organisations
Drive adoption of AI-powered antibody discovery and sequencing bioinformatics solutions
Shape go-to-market strategy for complex, science-led SaaS offerings
Partner closely with scientific, product, and data science teams to align commercial strategy with platform capabilities
Represent the organisation at senior industry forums, conferences, and partner engagements globally
Establish scalable commercial frameworks to support rapid international expansion
Key Requirements
Proven experience in AI-driven drug discovery platforms, ideally within antibody discovery, biologics, or computational biology
Strong background in bioinformatics, DNA/RNA sequencing technologies, or data-driven life sciences platforms
Track record of scaling enterprise SaaS businesses in pharma/biotech markets
Deep understanding of complex, long-cycle pharmaceutical sales and partnership models
Established global network across pharma, biotech, and computational biology ecosystems
Demonstrated success engaging with top-tier pharmaceutical organisations (Top 10 global pharma exposure essential)
Experience operating at executive level (CBO, Chief Commercial Officer, SVP Commercial or equivalent)
Strong leadership capability in building and scaling international teams
Location & Travel Requirements
Role is based in the Netherlands
Candidates must either relocate or maintain a minimum of one week per month presence in-country
Significant international travel required, particularly to Switzerland and the United States, due to strategic client and partner relationships
What This Opportunity Offers
Executive leadership role at the intersection of AI, drug discovery, and pharma innovation
Direct exposure to global pharmaceutical leaders and cutting-edge biologics discovery programmes
High-impact commercial mandate with global scale responsibility
Opportunity to shape the future of AI-enabled antibody and sequencing platforms
#J-18808-Ljbffr
